What happens in the body when a person with celiac disease eats gluten
Short answer
In celiac disease, gluten sets off an immune reaction that damages the small intestine2. How much a person feels it ranges from very mild to severe19, and in one challenge study some people who developed significant intestinal damage had no symptoms25.
Part of Symptoms, reactions and persistent complaints, 22 guides

Key points
- Gluten triggers an abnormal immune reaction that damages the small intestine2; the review in BMC Medicine ties it to blunted villi and the death of intestinal lining cells4.
- Symptoms vary from person to person, from very mild to severe19.
- In a 14-day challenge, symptom scores had no significant correlation with the biopsy and antibody measures, apart from one antibody link22.
- In a 12-week challenge, 22% of those who developed significant small-intestinal damage had no symptoms25.
- In one small study of everyday exposure on a gluten-free diet, most exposures were asymptomatic and unsuspected37.
What gluten sets off in the body
NIDDK describes celiac disease as a chronic digestive and immune disorder that damages the small intestine and is triggered by eating foods containing gluten1. In people who have it, consuming gluten triggers an abnormal immune system reaction that damages the small intestine2.
Coeliac UK names the target as the lining of the gut (the villi), where food and nutrients are absorbed3. A 2019 review in BMC Medicine gives a closer view: when CD4+ T cells in the lamina propria meet gluten they are activated and multiply, and the review ties that to crypt overgrowth and blunted villi, secondary to the death of intestinal lining cells induced by intraepithelial lymphocytes (IELs)4.
What the studies measured in the lining of the small intestine
The first study below is a challenge study, in which adults with celiac disease ate a measured amount of gluten and were then assessed. In it, 20 adults with biopsy-proven coeliac disease ate 3 or 7.5 grams of gluten a day for 14 days5. Between the start and day 14, the villous height to crypt depth ratio (Vh:Cd) fell from 2.2 to 1.1 and the intraepithelial lymphocyte (IEL) measure rose from 32.6 to 51.86.
The authors concluded that 14 days at 3 grams of gluten a day or more induces histological and serological changes in the majority of adults with coeliac disease7.
Those doses were grams a day, for two weeks. The exposures measured outside the lab in the study further down this page were typically in the milligram range8. The sources used here do not translate a challenge dose into a crumb.
What one large dose looked like in two trials
Two trials followed the hours after a single dose of about 6 grams of gluten in people with coeliac disease on a gluten-free diet. In the first, 25 people with coeliac disease and 25 healthy volunteers ate a standardised 6 gram gluten challenge9. Symptoms began after 1 hour and peaked in the third. Nausea and vomiting characterised severe reactions, while mild reactions were limited to headache and tiredness10. A blood marker, serum interleukin-2, was undetectable at baseline and above 0.5 pg/ml at 4 hours in 92% of the coeliac patients; it was always undetectable in the healthy controls11.
The second trial used 36 coeliac disease patients who had received placebo in a larger study. Each had a double-blind bolus of vital wheat gluten (about 6 grams of gluten protein) and, two weeks apart, a sham challenge low in FODMAPs12. Nausea (6% after sham, 61% after gluten) and vomiting (0% and 44%) were the only adverse events more common with gluten than with sham, with a median onset of 1:34 hours for nausea and 1:51 hours for vomiting13. The authors concluded that nausea and vomiting are relatively specific indicators of acute gluten ingestion and correlate with immune activation14.
Limits. Both used a single test dose of about 6 grams, and one reaction in a trial is not a script for every person. The authors of the second trial write that FODMAPs in gluten-containing foods, and participant anticipation of a harmful ("nocebo") effect, may contribute to acute symptoms after gluten challenge15. The abstracts list ImmusanT, Inc. among the authors' affiliations16, 17.
Why symptoms and damage do not always match
NIDDK says symptoms of celiac disease vary widely, and that a person may have several that come and go18. Coeliac UK says they range from very mild to severe19. NIDDK adds that some people have symptoms that affect other parts of the body20.
Two challenge studies show how feeling and damage can come apart22, 25. In the 14-day study, gastrointestinal symptoms rose significantly by day 3 and were back at baseline by day 2821. Apart from one link between the change in a symptom score and one antibody titre, the authors found no other significant correlation between symptoms, or change in symptoms, and the biopsy measures or antibody levels22.
In a 12-week study, 25 adults ate 1 to 3 grams or 3 to 5 grams of gluten a day23. Both low and moderate amounts induced small-bowel morphological damage in 67% of patients24. In 22% of those who developed significant small-intestinal damage, symptoms remained absent25.
NIDDK states that people with celiac disease who have no symptoms can still develop complications over time if they do not get treatment26.
Why reactions differ between people
The sources used here give no rule for predicting a given person's reaction. These are the differences they report:
- Amount, in the short term. In the 14-day study, no differences were seen between the 3 and 7.5 gram doses21. In the 12-week study, moderate doses (3 to 5 grams) also triggered mucosal inflammation and more symptoms, leading to premature withdrawals in seven cases23, 27.
- Small amounts, repeated. In a 90-day trial in 49 adults treated with a gluten-free diet28, patients took a daily capsule with 0, 10 or 50 mg of gluten29. One patient on 10 mg developed a clinical relapse, and the percentage change in Vh/Cd was 9% with placebo, -1% on 10 mg (95% CI -18%, 68%) and -20% on 50 mg (95% CI -22%, -13%)30.
- Age. NIDDK says digestive symptoms are more common in children than in adults31.
- Form of the disease. The 2019 review describes a subclinical form, with symptoms or signs below the clinical identification threshold, often recognizable only once the benefit of a gluten-free diet is seen32.
- The person's own pattern, which can change. The authors of the 12-week study note that some patients did not respond on any measure during the challenge33. They write that it is well known that celiac patients show varying sensitivity to gluten and that mucosal deterioration may take years or even decades34, and that the phenotype of the disease may vary in the same person over time35.
What one study found about everyday exposure on a gluten-free diet
A study followed adults with coeliac disease on a gluten-free diet for 10 days36. Twelve of the 18 had a median of 2.1 mg of gluten per exposure (range 0.2 to more than 80 mg), and most exposures were asymptomatic and unsuspected37. The authors concluded that exposure on a gluten-free diet is common, intermittent and usually silent38.
NIDDK says some other products can be hidden sources of gluten: a person may take in small amounts by consuming them, using them around the mouth, or transferring them from hands to mouth by accident39. Our guides on hidden sources of gluten and cross-contamination cover where those small amounts come from.
One small study. Its authors call their findings likely a "best case" because participants were highly engaged and had access to dietitians with gluten-free diet expertise40.
What the sources say about repeated exposure and follow-up
NIDDK says symptoms typically improve and may go away on a gluten-free diet, and may return if a person consumes small amounts of gluten41.
It reports that in about 20 percent of people with celiac disease, symptoms continue or come back on a gluten-free diet, and lists small amounts of gluten, other health problems and refractory celiac disease as possible causes42.
NIDDK says follow-up may include antibody blood tests, which are higher in untreated celiac disease but typically return to normal after treatment, and in some cases biopsies to find out whether the small intestine has healed43. The 14-day challenge study adds a timing detail: antibody titres rose only slightly by day 14 and markedly by day 2844.
Questions people ask
Can someone with celiac disease have no symptoms and still be affected?
In a 12-week challenge study, 22% of those who developed significant small-intestinal damage had no symptoms25. NIDDK says people with celiac disease who have no symptoms can still develop complications over time if they do not get treatment26.
Do small amounts of gluten matter?
NIDDK says symptoms may return if a person consumes small amounts of gluten41. In one 90-day trial, the percentage change in Vh/Cd was -20% in the group taking 50 mg a day, against 9% with placebo30. This guide does not set an amount that applies to everyone; the 90-day trial is one study.
More in Symptoms, reactions and persistent complaints
Celiac disease symptoms in adults: what the sources list and who gets testedDigestive and non-digestive celiac symptoms as NIDDK, ACG and Coeliac UK list them, who guidelines say to test, and why gluten stays in the diet first.
Still having symptoms on a gluten-free diet? Where gluten can still get inA checklist of label, kitchen, restaurant, product and medicine sources of gluten, and what the sources say about when to see a doctor.
If you think you were glutened: what the celiac organizations say to doWhat the celiac charities, FDA and NIDDK say to do after accidental gluten exposure, when to contact a clinician, and how to trace the cause.
How long after eating gluten do symptoms start, and how long do they last?Onset and duration after gluten as celiac charities and studies report them, and how sources time celiac disease, gluten sensitivity and wheat allergy.
Still tired on a gluten-free diet: the causes clinicians checkWhy fatigue can continue on a gluten-free diet: gluten exposure, other gut conditions, iron, B12, thyroid, sleep, mood, and follow-up lists.
Non-responsive celiac disease: what clinicians check, and in what orderWhat guidelines say clinicians check when celiac disease does not settle on the diet: gluten exposure, antibodies, biopsy, other causes.
All 22 guides in Symptoms, reactions and persistent complaints
Related guides
Where wheat, barley and rye hide in processed food: 15 places to checkFifteen processed foods where wheat, barley or rye turn up, the label step that catches each, and what US allergen law does and does not flag.
A food and symptom diary for tracking possible gluten exposureWhat to write in a food and symptom diary on a gluten-free diet, how to read it, a template to copy, and what to bring to a dietitian or doctor.
How long celiac healing takes: symptoms, antibodies and the gut liningWhat studies report on how long symptoms, blood antibodies and the intestinal lining take to recover on a gluten-free diet, and what to ask your care team.
How celiac disease damages the small intestine, step by stepThe steps from gluten to blunted villi in celiac disease: the genes, the immune response, how damage is graded and which test shows which step.
Sources
- [1, 45, 46] US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Definition & Facts for Celiac Disease, checked Nov 17, 2026.
- [2, 39, 42, 43] US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Treatment for Celiac Disease, checked Nov 17, 2026.
- [3, 19] Coeliac UK, What Causes Coeliac Disease? Genetics and Risks, checked Nov 17, 2026.
- [4, 32] BMC Medicine (Caio et al., 2019), via PubMed Central, Celiac disease: a comprehensive current review, checked Nov 17, 2026.
- [5, 6, 7, 21, 22, 44] Gut (Leffler et al., 2013), via PubMed Central, Kinetics of the histologic, serologic and symptomatic responses to gluten challenge in adults with coeliac disease, checked Nov 17, 2026.
- [8, 36, 37, 38, 40] Alimentary Pharmacology & Therapeutics (Silvester et al., 2020), via PubMed Central, Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten-free diet, checked Nov 17, 2026.
- [9, 10, 11, 16] Alimentary Pharmacology & Therapeutics (Tye-Din et al., 2019), via PubMed, Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease, checked Nov 17, 2026.
Read on 2026-11-17: the author affiliations listed with the abstract include ImmusanT, Inc., Cambridge, MA, USA.
- [12, 13, 14, 15, 17] Alimentary Pharmacology & Therapeutics (Daveson et al., 2020), via PubMed, Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease, checked Nov 17, 2026.
Read on 2026-11-17: the author affiliations listed with the abstract include ImmusanT, Inc., Cambridge, MA, USA.
- [18, 20, 26, 31, 41] US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Symptoms & Causes of Celiac Disease, checked Nov 17, 2026.
- [23, 24, 25, 27, 33, 34, 35] BMC Gastroenterology (Lähdeaho et al., 2011), via PubMed Central, Small-bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease, checked Nov 17, 2026.
- [28, 29, 30] American Journal of Clinical Nutrition (Catassi et al., 2007), via PubMed, Ninety-day trial of 0, 10 or 50 mg gluten a day in treated adults, checked Nov 17, 2026.